Company name | Market Cap | Revenue | EPS | Last quarter Revenue growth | Last quarter EPS growth | Last quarter Revenue surprise | Last quarter EPS surprise | Next quarter Revenue growth | Next quarter EPS growth | Last 10 Earnings (how many miss vs beat) | 1Y Fwd Revenue growth | 1Y Fwd EPS growth |
$34.9B | $4,033.0M | $1.47 | 7.6% | (43.3%) | Beat by 1.2% | Miss by 25.4% | (7.4%) | 0.3% | Beats: 8 Misses: 2 | 14.3% | 42.2% | |
$242.4B | $42.0B | $7.74 | 7.2% | 479.3% | Miss by 0.5% | Beat by 299.2% | (2.9%) | (79.2%) | Beats: 8 Misses: 2 | 7.3% | (33.4%) | |
$154.5B | $16.7B | $0.88 | 22.4% | (100.0%) | Beat by 3.2% | Miss by 100.0% | (2.3%) | 0.0% | Beats: 8 Misses: 2 | 12.2% | 122.5% | |
$150.5B | $22.6B | $7.86 | 10.7% | (52.5%) | Beat by 1.2% | Miss by 63.1% | (11.5%) | 99.0% | Beats: 8 Misses: 2 | 8.0% | 71.8% | |
$120.9B | $33.2B | $0.49 | 2.5% | N/A | undefinedN/A | undefinedN/A | 0.4% | (175.5%) | Beats: 9 Misses: 1 | 3.7% | 96.8% | |
$43.4B | $5,872.6M | $6.94 | (8.5%) | 715.9% | Miss by 18.1% | Beat by 640.4% | 0.3% | (89.3%) | Beats: 6 Misses: 4 | 7.1% | (65.0%) | |
$24.7B | €18.0B | (€0.79) | (0.4%) | N/A | Miss by 14.5% | Miss by 168.2% | (3.2%) | (215.9%) | Beats: 2 Misses: 6 | 10.0% | (246.6%) | |
$21.9B | $5,398.4M | $4.74 | (1.8%) | 23.9% | Miss by 0.8% | Miss by 24.2% | 9.1% | 48.9% | Beats: 6 Misses: 4 | 7.0% | 138.5% | |
$21.6B | $5,655.4M | $3.25 | (100.0%) | (100.0%) | Miss by 100.0% | Miss by 100.0% | 0.0% | 0.0% | Beats: Misses: | 3.7% | 62.6% | |
$19.4B | $1,900.3M | $6.05 | 17.2% | (2.7%) | Beat by 2.6% | Beat by 43.5% | (9.0%) | (46.5%) | Beats: 9 Misses: 1 | 21.2% | 8.4% |
DexCom, Inc.'s last earnings date was Sep'24 (Q3 2024).
DexCom, Inc.'s EPS was $0.38, with a 25.4% miss.
DexCom, Inc.'s revenue was $1,113.5M, with a 1.2% beat.
DexCom, Inc.'s next quarter EPS estimate is $0.52, with an expected 4.0% YoY growth.